|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.8 USD | -0.55% |
|
0.00% | -5.26% |
| Apr. 18 | Verastem Names John Hayslip as Chief Medical Officer | MT |
| Apr. 15 | I-Mab Announces Chief Medical Officer Changes | CI |
I-Mab reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was CNY 27.64 million compared to negative revenue of CNY 221.56 million a year ago. Net loss was CNY 1,465.69 million compared to CNY 2,507.32 million a year ago.
Basic loss per share from continuing operations was CNY 16.537 compared to CNY 30.383 a year ago. Diluted loss per share from continuing operations was CNY 16.537 compared to CNY 30.383 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -5.26% | 145M | |
| +25.83% | 661B | |
| +27.17% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +14.32% | 231B | |
| +4.55% | 200B | |
| -9.53% | 195B | |
| -6.26% | 145B |
I-MAB 
